Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Advisory Committees | 17 | 2026 | 23 | 1.900 |
Why?
|
| United States | 23 | 2026 | 1019 | 1.460 |
Why?
|
| Pandemics | 3 | 2023 | 87 | 1.260 |
Why?
|
| Racism | 3 | 2020 | 49 | 0.920 |
Why?
|
| Humans | 24 | 2026 | 6794 | 0.880 |
Why?
|
| Public Health | 2 | 2026 | 40 | 0.870 |
Why?
|
| Vaccination | 8 | 2026 | 49 | 0.860 |
Why?
|
| Immunization | 9 | 2023 | 19 | 0.850 |
Why?
|
| Poliomyelitis | 1 | 2023 | 1 | 0.830 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2023 | 1 | 0.830 |
Why?
|
| Poliovirus | 1 | 2023 | 1 | 0.830 |
Why?
|
| Police | 2 | 2020 | 4 | 0.810 |
Why?
|
| Societies, Medical | 3 | 2021 | 67 | 0.800 |
Why?
|
| Maternal Mortality | 2 | 2020 | 5 | 0.790 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 83 | 0.750 |
Why?
|
| Physicians | 2 | 2019 | 49 | 0.730 |
Why?
|
| Health Status Disparities | 2 | 2019 | 83 | 0.700 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 145 | 0.700 |
Why?
|
| Human Rights | 1 | 2020 | 3 | 0.660 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2025 | 3 | 0.640 |
Why?
|
| Physician's Role | 1 | 2020 | 15 | 0.640 |
Why?
|
| Maternal Health Services | 1 | 2020 | 5 | 0.630 |
Why?
|
| Violence | 1 | 2020 | 52 | 0.630 |
Why?
|
| Cultural Diversity | 1 | 2019 | 16 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 84 | 0.570 |
Why?
|
| Respiratory Tract Infections | 2 | 2025 | 11 | 0.440 |
Why?
|
| Vaccines | 2 | 2026 | 10 | 0.430 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2023 | 2 | 0.410 |
Why?
|
| Communicable Diseases | 2 | 2023 | 8 | 0.410 |
Why?
|
| Health Policy | 2 | 2026 | 26 | 0.400 |
Why?
|
| Female | 7 | 2025 | 4060 | 0.360 |
Why?
|
| Immunization Schedule | 4 | 2024 | 7 | 0.340 |
Why?
|
| Adult | 7 | 2024 | 2113 | 0.330 |
Why?
|
| Adolescent | 5 | 2024 | 869 | 0.330 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2025 | 2 | 0.260 |
Why?
|
| Pregnancy | 3 | 2025 | 599 | 0.230 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2025 | 26 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 31 | 0.230 |
Why?
|
| Male | 4 | 2022 | 3671 | 0.230 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2023 | 1 | 0.210 |
Why?
|
| New York | 1 | 2023 | 7 | 0.210 |
Why?
|
| Infant | 4 | 2025 | 187 | 0.210 |
Why?
|
| Health Planning Guidelines | 1 | 2022 | 1 | 0.180 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 2 | 0.180 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 29 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 53 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 567 | 0.160 |
Why?
|
| Politics | 1 | 2019 | 7 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 147 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2020 | 167 | 0.150 |
Why?
|
| Medicare | 1 | 2019 | 57 | 0.150 |
Why?
|
| Aged | 4 | 2024 | 1539 | 0.140 |
Why?
|
| Drug Approval | 3 | 2021 | 6 | 0.130 |
Why?
|
| Child | 3 | 2024 | 524 | 0.130 |
Why?
|
| Middle Aged | 4 | 2024 | 2108 | 0.130 |
Why?
|
| Child, Preschool | 2 | 2024 | 258 | 0.100 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2022 | 4 | 0.090 |
Why?
|
| United States Food and Drug Administration | 2 | 2021 | 7 | 0.090 |
Why?
|
| Immunization Programs | 1 | 2026 | 2 | 0.060 |
Why?
|
| Policy Making | 1 | 2026 | 5 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2025 | 199 | 0.060 |
Why?
|
| Immunization, Secondary | 1 | 2022 | 3 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2022 | 190 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 19 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 2 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2022 | 197 | 0.040 |
Why?
|